CM Life Sciences Statistics Share Statistics CM Life Sciences has n/a
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 241.9M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 813, so 0% of the outstanding
shares have been sold short.
Short Interest 813 Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -5.97 and the forward
PE ratio is null.
CM Life Sciences's PEG ratio is
0.
PE Ratio -5.97 Forward PE n/a PS Ratio 1.02 Forward PS n/a PB Ratio 1.27 P/FCF Ratio -9.18 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for CM Life Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.61,
with a Debt / Equity ratio of 0.26.
Current Ratio 3.61 Quick Ratio 3.42 Debt / Equity 0.26 Debt / EBITDA -2.77 Debt / FCF -1.89 Interest Coverage 7.66
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0.73 Inventory Turnover 10.43
Taxes Income Tax -343K Effective Tax Rate 0.65%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so CM Life Sciences's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) n/a Average Volume (20 Days) 10,023
Income Statement In the last 12 months, CM Life Sciences had revenue of 305.45M
and earned -52.29M
in profits. Earnings per share was -1.94.
Revenue 305.45M Gross Profit 194.4M Operating Income -23.21M Net Income -52.29M EBITDA -23.21M EBIT n/a Earnings Per Share (EPS) -1.94
Full Income Statement Balance Sheet The company has 85.21M in cash and 64.25M in
debt, giving a net cash position of 20.96M.
Cash & Cash Equivalents 85.21M Total Debt 64.25M Net Cash 20.96M Retained Earnings -1.35B Total Assets 463.86M Working Capital 133.43M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -28.5M
and capital expenditures -5.49M, giving a free cash flow of -33.99M.
Operating Cash Flow -28.5M Capital Expenditures -5.49M Free Cash Flow -33.99M FCF Per Share -1.26
Full Cash Flow Statement Margins Gross margin is 63.64%, with operating and profit margins of -7.6% and -17.12%.
Gross Margin 63.64% Operating Margin -7.6% Pretax Margin -17.23% Profit Margin -17.12% EBITDA Margin -7.6% EBIT Margin -7.6% FCF Margin -11.13%
